| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 08/11/2005 | US20050176733 Chk-1 inhibitors |
| 08/11/2005 | US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines |
| 08/11/2005 | US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 08/11/2005 | US20050176717 N-(3-Amino-propyl)-N-[(3-benzyl-quinoxalin-2-yl)-cyclopropyl-methyl]-4-methylbenzamide; antiproliferative, antitumor agent, viricide; inhibitor of Eg5 protein, associated with proliferating cells in metaphase stage of mitosis; mitotic arrest and apoptosis; small molecules |
| 08/11/2005 | US20050176716 (2,3-5,6 aryl-heteroaryl)-bicyclo(2,2,2,)octane-amide derivatives; antiinflammatory, obesity, antidiabetic agent, autoimmune disease, asthma, arthritis; non-steroidal; side effect reduction; pharmacokinetics |
| 08/11/2005 | CA2554387A1 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 08/10/2005 | EP1515956A4 Peptide deformylase inhibitors |
| 08/10/2005 | CN1653056A Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making |
| 08/10/2005 | CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1651417A Preparation method of acymose |
| 08/09/2005 | US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation |
| 08/09/2005 | US6927214 Non-peptide GLP-1 agonists |
| 08/09/2005 | CA2199786C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 08/09/2005 | CA2105518C Condensed heterocyclic compounds, their production and use |
| 08/04/2005 | WO2005070207A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 08/04/2005 | WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 08/04/2005 | US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 08/04/2005 | US20050171181 Histamine-3 receptor modulators |
| 08/04/2005 | US20050171136 Modulators of the glucocorticoid receptor and method |
| 08/04/2005 | US20050171120 At the 1-position with an alkyl or aryl 1-(4-trifluoromethylphenyl)-2-methoxyethyl sulfonate, deprotecting; coupling methyl 4-trifluoromethylbenzoate with methyl methoxyacetate, hydrolyzing to form 4-trifluoromethyl methoxyacetophenone; 2-methyl-4-trifluoromethylcarbonyl-piperazine; CCR5 antagonists |
| 08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/04/2005 | US20050171102 Semicarbazide derivatives for combating thromboembolic diseases |
| 08/04/2005 | US20050171098 MCH antagonists and their use in the treatment of obesity |
| 08/04/2005 | US20050171061 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 08/03/2005 | EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 08/03/2005 | EP1558587A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 08/03/2005 | EP1558586A2 Inhibitors of akt activity |
| 08/03/2005 | EP1558585A1 Neurologically-active compounds |
| 08/03/2005 | EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 08/03/2005 | CN1649969A Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 08/03/2005 | CN1649859A Substituted phenylacetamides and their use as glucokinase activators |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649829A Novel florfenicol-type antibiotics |
| 08/03/2005 | CN1648122A Malononitrile compounds and its use |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/02/2005 | US6924374 Modulators of dopamine neurotransmission |
| 08/02/2005 | US6924284 PARP inhibitors |
| 08/02/2005 | US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 07/28/2005 | WO2005068446A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof |
| 07/28/2005 | WO2005068445A2 Pesticidal heterocyclic dihaloallyl compounds |
| 07/28/2005 | WO2005068439A1 Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof |
| 07/28/2005 | WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/28/2005 | WO2005025496B1 Aliphatic pyrazinoylguanidine sodium channel blockers |
| 07/28/2005 | US20050165067 Aryl sulfonamides |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164225 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium moieties; labels for polynucleotides, nucleosides, nucleotides, and polypeptides; fluorescence resonance energy transfer |
| 07/28/2005 | CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557168A2 Biarylurea Derivatives |
| 07/27/2005 | EP1556361A2 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound |
| 07/27/2005 | EP1133490B1 Piperazinone derivatives |
| 07/27/2005 | CN1646127A Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/26/2005 | US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/26/2005 | US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/21/2005 | WO2005066156A1 Selective kinase inhibitors |
| 07/21/2005 | WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators |
| 07/21/2005 | WO2005066116A1 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors |
| 07/21/2005 | WO2005033119A9 Supramolecular compounds and their use as antitumour and antiviral agents |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | US20050159422 Inhibitors of akt activity |
| 07/21/2005 | CA2552090A1 Disubstituted chalcone oximes as selective agonists of rar.gamma. retinoid receptors |
| 07/20/2005 | EP1555259A1 Malononitrile compounds as pesticides |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554258A1 5-substituted-2-arylpyrazines as modulators of crf receptors |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642930A Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1640870A Ibuprofen ester, medically-acceptable salt, and its preparing process and medicinal composition |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/19/2005 | US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063247A1 Aryl sulfonamide compounds and uses related thereto |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050153984 4-[5-(4-trifluoromethyl-phenyl)-pyridin-3-yloxy]-benzothiazol-2-ylamine; inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 07/14/2005 | CA2548309A1 Aryl sulfonamide compounds and uses related thereto |
| 07/13/2005 | EP1551902A2 Anisotropic films based on 1,8-naphthoylene-1 ,2 -benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |